Thalidomide for the control of severe paraneoplastic pruritus associated with hodgkin's disease

American Journal of Hospice and Palliative Medicine

Volumn 27, Issue 7, 2010, Pages 486-487

  Gonçalves, Ferraz ^a  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

Hodgkin's disease; itch; palliative care; thalidomide

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; THALIDOMIDE;

ADULT; ARTICLE; CASE REPORT; FATALITY; FEMALE; HODGKIN DISEASE; HUMAN; METHODOLOGY; PALLIATIVE THERAPY; PARANEOPLASTIC SYNDROME; PRURITUS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FATAL OUTCOME; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PALLIATIVE CARE; PARANEOPLASTIC SYNDROMES; PRURITUS; THALIDOMIDE; YOUNG ADULT;

EID: 78049319454     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909110362523     Document Type: Article

References (7)

1. Rubinstein M., Duvic M. Cutaneous manifestations of Hodgkin's disease. Int J Dermatol. 2006;45(3):251-256.
2. Twycross R., Greaves MW, Handwerker H.,et al.Itch: scratching more than the surface. QJM. 2003;96(1):7-26.
3. Franks ME, Macpherson GR, Figg WD Thalidomide. Lancet. 2004;363(9423):1802-1811.
4. Summey BT, Yosipovitch G. Pharmacologic advances in the systemic treatment of itch. Dermatol Ther. 2005;18(4):328-332.
5. Daly BM, Shuster S. Antipruritic action of thalidomide. Acta Derm Venereol. 2000;80(1):24-25.
6. Wu JJ, Huang DB, Pang KR, Hsu S., Tyring SK Thalidomide: dermatological indications, mechanisms of action and side effects. Br J Dermatol. 2005;153(2):254-273.
7. Korfitis C., Trafalis TD Carbamazepine can be effective in alleviating tormenting pruritus in patients with haematological malignancy. J Pain Symptom Manage. 2008;35(6):571-572.